Literature DB >> 23793904

Effect of HDAC inhibitors on neuroprotection and neurite outgrowth in primary rat cortical neurons following ischemic insult.

Mohammad Rakibul Hasan1, Ji-Hye Kim, Youn Jung Kim, Kyoung Ja Kwon, Chan Young Shin, Hahn Young Kim, Seol-Heui Han, Dong-Hee Choi, Jongmin Lee.   

Abstract

Histone deacetylase inhibitors (HDACi)-valproic acid (VPA) and trichostatin A (TSA) promote neurogenesis, neurite outgrowth, synaptic plasticity and neuroprotection. In this study, we investigated whether VPA and TSA promote post-ischemic neuroprotection and neuronal restoration in rat primary cortical neurons. On 6 days in vitro (DIV), cortical neurons were exposed to oxygen-glucose deprivation for 90 min. Cells were returned to normoxic conditions and cultured for 1, 3, or 7 days with or without VPA and TSA. Control cells were cultured in normoxic conditions only. On 7, 9, and 13 DIV, cells were measured neurite outgrowth using the Axiovision program and stained with Tunel staining kit. Microtubule associated protein-2 immunostaining and tunel staining showed significant recovery of neurite outgrowth and post-ischemic neuronal death by VPA or TSA treatment. We also determined levels of acetylated histone H3, PSD95, GAP 43 and synaptophysin. Significant increases in all three synaptic markers and acetylated histone H3 were observed relative to non-treated cells. Post-ischemic HDACi treatment also significantly raised levels of brain derived neurotrophic factor (BDNF) expression and secreted BDNF. Enhanced BDNF expression by HDACi treatment might have been involved in the post-ischemic neuroprotection and neuronal restorative effects. Our findings suggest that both VPA and TSA treatment during reoxygenation after ischemia may help post-ischemic neuroprotection and neuronal regeneration via increased BDNF expression and activation.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23793904     DOI: 10.1007/s11064-013-1098-9

Source DB:  PubMed          Journal:  Neurochem Res        ISSN: 0364-3190            Impact factor:   3.996


  34 in total

1.  Identification of novel isoform-selective inhibitors within class I histone deacetylases.

Authors:  Erding Hu; Edward Dul; Chiu-Mei Sung; Zunxuan Chen; Robert Kirkpatrick; Gui-Feng Zhang; Kyung Johanson; Ronggang Liu; Amparo Lago; Glenn Hofmann; Ricardo Macarron; Maite de los Frailes; Paloma Perez; John Krawiec; James Winkler; Michael Jaye
Journal:  J Pharmacol Exp Ther       Date:  2003-09-15       Impact factor: 4.030

2.  Histone deacetylase inhibitors exhibit anti-inflammatory and neuroprotective effects in a rat permanent ischemic model of stroke: multiple mechanisms of action.

Authors:  Hyeon Ju Kim; Michael Rowe; Ming Ren; Jau-Shyong Hong; Po-See Chen; De-Maw Chuang
Journal:  J Pharmacol Exp Ther       Date:  2007-03-19       Impact factor: 4.030

3.  Intravenous basic fibroblast growth factor (bFGF) decreases DNA fragmentation and prevents downregulation of Bcl-2 expression in the ischemic brain following middle cerebral artery occlusion in rats.

Authors:  I Ay; H Sugimori; S P Finklestein
Journal:  Brain Res Mol Brain Res       Date:  2001-02-19

4.  Extensive cortical rewiring after brain injury.

Authors:  Numa Dancause; Scott Barbay; Shawn B Frost; Erik J Plautz; Daofen Chen; Elena V Zoubina; Ann M Stowe; Randolph J Nudo
Journal:  J Neurosci       Date:  2005-11-02       Impact factor: 6.167

5.  Novel targets for valproic acid: up-regulation of melatonin receptors and neurotrophic factors in C6 glioma cells.

Authors:  Lyda M Rincón Castro; Michel Gallant; Lennard P Niles
Journal:  J Neurochem       Date:  2005-12       Impact factor: 5.372

Review 6.  Synaptic, intracellular, and neuroprotective mechanisms of anticonvulsants: are they relevant for the treatment and course of bipolar disorders?

Authors:  Xiaohua Li; Terence A Ketter; Mark A Frye
Journal:  J Affect Disord       Date:  2002-05       Impact factor: 4.839

Review 7.  Experimental models of head trauma.

Authors:  R R Leker; E Shohami; S Constantini
Journal:  Acta Neurochir Suppl       Date:  2002

8.  Sodium- and magnesium-valproate in vivo modulate glutamatergic and GABAergic synapses in the medial prefrontal cortex.

Authors:  Gabriella Gobbi; Luigi Janiri
Journal:  Psychopharmacology (Berl)       Date:  2006-02-22       Impact factor: 4.530

9.  Histone deacetylase inhibitors up-regulate astrocyte GDNF and BDNF gene transcription and protect dopaminergic neurons.

Authors:  Xuefei Wu; Po See Chen; Shannon Dallas; Belinda Wilson; Michelle L Block; Chao-Chuan Wang; Harriet Kinyamu; Nick Lu; Xi Gao; Yan Leng; De-Maw Chuang; Wanqin Zhang; Ru Band Lu; Jau-Shyong Hong
Journal:  Int J Neuropsychopharmacol       Date:  2008-07-09       Impact factor: 5.176

10.  The influence of developmental periods of sodium valproate exposure on synaptic plasticity in the CA1 region of rat hippocampus.

Authors:  Min-Min Zhang; Kuai Yu; Cheng Xiao; Di-Yun Ruan
Journal:  Neurosci Lett       Date:  2003-11-20       Impact factor: 3.046

View more
  17 in total

1.  ANKRD11 associated with intellectual disability and autism regulates dendrite differentiation via the BDNF/TrkB signaling pathway.

Authors:  Minhan Ka; Woo-Yang Kim
Journal:  Neurobiol Dis       Date:  2017-12-21       Impact factor: 5.996

2.  Valproic Acid Promotes Survival of Facial Motor Neurons in Adult Rats After Facial Nerve Transection: a Pilot Study.

Authors:  Lili Zhang; Zhaomin Fan; Yuechen Han; Lei Xu; Wenwen Liu; Xiaohui Bai; Meijuan Zhou; Jianfeng Li; Haibo Wang
Journal:  J Mol Neurosci       Date:  2018-03-12       Impact factor: 3.444

3.  Inhibition of histone methyltransferases SUV39H1 and G9a leads to neuroprotection in an in vitro model of cerebral ischemia.

Authors:  Sophie Schweizer; Christoph Harms; Heike Lerch; Jennifer Flynn; Jochen Hecht; Ferah Yildirim; Andreas Meisel; Stefanie Märschenz
Journal:  J Cereb Blood Flow Metab       Date:  2015-05-13       Impact factor: 6.200

Review 4.  The Emerging Role of Epigenetics in Cerebral Ischemia.

Authors:  Zhiping Hu; Bingwu Zhong; Jieqiong Tan; Chunli Chen; Qiang Lei; Liuwang Zeng
Journal:  Mol Neurobiol       Date:  2016-02-19       Impact factor: 5.590

Review 5.  Valproic acid: a new candidate of therapeutic application for the acute central nervous system injuries.

Authors:  Sheng Chen; Haijian Wu; Damon Klebe; Yuan Hong; Jianmin Zhang
Journal:  Neurochem Res       Date:  2014-01-31       Impact factor: 3.996

Review 6.  Valproic Acid: A Potential Therapeutic for Spinal Cord Injury.

Authors:  Conghui Zhou; Songfeng Hu; Benson O A Botchway; Yong Zhang; Xuehong Liu
Journal:  Cell Mol Neurobiol       Date:  2020-07-28       Impact factor: 5.046

7.  Involvement of HDAC1 and HDAC3 in the Pathology of Polyglutamine Disorders: Therapeutic Implications for Selective HDAC1/HDAC3 Inhibitors.

Authors:  Elizabeth A Thomas
Journal:  Pharmaceuticals (Basel)       Date:  2014-05-26

Review 8.  Histone Deacetylase (HDAC) Inhibitors - emerging roles in neuronal memory, learning, synaptic plasticity and neural regeneration.

Authors:  Shabir Ahmad Ganai; Mahalakshmi Ramadoss; Vijayalakshmi Mahadevan
Journal:  Curr Neuropharmacol       Date:  2016       Impact factor: 7.363

9.  Dual mechanisms for the regulation of brain-derived neurotrophic factor by valproic acid in neural progenitor cells.

Authors:  Hyun Myung Ko; Yeonsun Jin; Hyun Ho Park; Jong Hyuk Lee; Seung Hyo Jung; So Young Choi; Sung Hoon Lee; Chan Young Shin
Journal:  Korean J Physiol Pharmacol       Date:  2018-10-25       Impact factor: 2.016

10.  IL-10 Promotes Neurite Outgrowth and Synapse Formation in Cultured Cortical Neurons after the Oxygen-Glucose Deprivation via JAK1/STAT3 Pathway.

Authors:  Hongbin Chen; Wei Lin; Yixian Zhang; Longzai Lin; Jianhao Chen; Yongping Zeng; Mouwei Zheng; Zezhong Zhuang; Houwei Du; Ronghua Chen; Nan Liu
Journal:  Sci Rep       Date:  2016-07-26       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.